CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
Read full articleWhat obesity drugmakers see next in the market: More pills, easier access and drug combinations
Written on 01/23/2026

